An Intact Overexpressed E-cadherin/alpha,beta-catenin Axis Characterizes the Lymphovascular Emboli of Inflammatory Breast Carcinoma
Overview
Authors
Affiliations
The step of intravasation (lymphovascular invasion), a rate-limiting step in metastasis, is greatly exaggerated in inflammatory breast carcinoma (IBC). Because nearly all human breast carcinoma cell lines grow as solitary nodules in nude/severe combined immunodeficient mice without manifesting lymphovascular invasion, this step has been difficult to study. We captured the essence of the IBC phenotype by establishing a unique human transplantable IBC xenograft, MARY-X, which manifests florid lymphovascular emboli in severe combined immunodeficient/nude mice. Comparing MARY-X with common non-IBC cell lines/xenografts, we discovered an overexpressed and overfunctioning E-cadherin/alpha,beta-catenin axis. In MARY-X, the E-cadherin and catenins were part of a structurally and functionally intact adhesion axis involving the actin cytoskeleton. In vitro, MARY-X grew as round compact spheroids with a cell density 5-10-fold higher than that of other lines. The spheroids of MARY-X completely disadhered when placed in media containing absent Ca(2+) or anti-E-cadherin antibodies or when retrovirally transfected with a dominant-negative E-cadherin mutant (H-2K(d)-E-cad). Anti-E-cadherin antibodies injected i.v. immunolocalized to the pulmonary lymphovascular emboli of MARY-X and caused their dissolution. H-2K(d)-E-cad-transfected MARY-X spheroids were only weakly tumorigenic and did not form lymphovascular emboli. A total of 90% of human IBCs showed increased membrane E-cadherin/alpha,beta-catenin immunoreactivity. These findings indicate that it is the gain and not the loss of the E-cadherin axis that contributes to the IBC phenotype.
Wang J, Hoffman R, Ye Y, Dillard J, Barsky S Lymphatics. 2024; 2(4):195-211.
PMID: 39669476 PMC: 11632961. DOI: 10.3390/lymphatics2040016.
Initiation of tumor dormancy by the lymphovascular embolus.
Ye Y, Wang J, Izban M, Ballard B, Barsky S Oncotarget. 2024; 15:726-740.
PMID: 39392391 PMC: 11468568. DOI: 10.18632/oncotarget.28658.
Unique Cohorts of Salivary Gland Cancer Cells as an Model of Circulating Tumor Cells.
Mincy C, Revelt L, Carter K, Reed D, Joy A J Maxillofac Oral Surg. 2024; 23(4):896-908.
PMID: 39118911 PMC: 11303642. DOI: 10.1007/s12663-024-02250-0.
Rickard A, Sannareddy D, Bennion A, Patel P, Sauer S, Rouse D Cancers (Basel). 2023; 15(8).
PMID: 37190189 PMC: 10137020. DOI: 10.3390/cancers15082261.
Balamurugan K, Poria D, Sehareen S, Krishnamurthy S, Tang W, McKennett L JCI Insight. 2023; 8(6).
PMID: 36757813 PMC: 10070121. DOI: 10.1172/jci.insight.156057.